Skip to main content

AdAlta secures A$1.28 million in rights offer to advance AD-214

AdAlta Ltd (ASX:1AD) managing director Dr Tim Oldham tells Proactive the company’s rights offer has raised A$1.28 million before costs, with commitments in hand to achieve the balance of the A$3.15 million target. The proceeds will help fund the early return to the clinic for lead asset AD-214 as well as progress partnering discussions.

Contact Details

Proactive Investors

Jonathan Jackson

+61 413 713 744

Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.